Stock Quote (NASDAQ: NSTG)
Price:
14.71
Change:
+ 0.65
Day High:
14.72
Day Low:
13.85
Volume:
35,700
11:02 AM ET on Jun 03, 2015
Delayed at least 20 minutes.
Provided by eSignal.


Search Investor Relations

Press Releases

All Releases
View Summary PRESS RELEASEJun 01, 2015
NanoString Technologies Highlights Results from Three Significant New Prosigna Studies Presented at the 51st Annual Meeting of the American Society of Clinical Oncology
read more
View Summary PRESS RELEASEMay 28, 2015
Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)
read more
View Summary PRESS RELEASEMay 14, 2015
NanoString Technologies Announces Favorable Draft Local Coverage Determination by Palmetto GBA for Its Prosigna Breast Cancer Assay
read more
View Summary PRESS RELEASEMay 12, 2015
St. Gallen International Breast Cancer Guidelines Recognize Power of Prosigna/PAM50 to Inform Treatment Decisions and Spare Low Risk Breast Cancer Patients Unnecessary Chemotherapy
read more
View Summary PRESS RELEASEMay 07, 2015
NanoString Technologies to Present at the UBS Global Healthcare Conference
read more
View Summary PRESS RELEASEMay 06, 2015
NanoString Technologies Releases Financial Results for First Quarter of 2015
read more
View Summary PRESS RELEASEMay 05, 2015
NanoString Technologies and Cancer Immunotherapy Trials Network (CITN) Enter Into a Collaboration to Identify Biomarker Assays for Novel Cancer Immunotherapies
read more
View Summary PRESS RELEASEApr 22, 2015
NanoString Technologies to Release First Quarter 2015 Financial Results and Host Conference Call on Wednesday, May 6, 2015
read more
View Summary PRESS RELEASEApr 16, 2015
NanoString Technologies Empowers Cancer Researchers With Three Innovative New Products for the nCounter Analysis System
read more
View Summary PRESS RELEASEApr 01, 2015
NanoString Technologies and MD Anderson to Collaborate on Development of Multi-Omic Assays Simultaneously Profiling Gene and Protein Expression
read more
View Summary PRESS RELEASEMar 18, 2015
NanoString Technologies' Prosigna Breast Cancer Assay Included in German Breast Cancer Treatment Guidelines
read more
View Summary PRESS RELEASEMar 03, 2015
NanoString Technologies Appoints Robert Hershberg, M.D., Ph.D. to Its Board of Directors
read more
View Summary PRESS RELEASEFeb 24, 2015
NanoString Technologies Releases Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Outlook
read more
View Summary PRESS RELEASEFeb 18, 2015
NanoString Technologies to Present at the Cowen 35th Annual Health Care Conference
read more
View Summary PRESS RELEASEFeb 10, 2015
NanoString Technologies to Release Fourth Quarter 2014 Financial Results and Host Conference Call on Tuesday, February 24, 2015
read more
View Summary PRESS RELEASEJan 28, 2015
NanoString Technologies to Present at 2015 Leerink Global Healthcare Conference
read more
View Summary PRESS RELEASEJan 08, 2015
NanoString Technologies Provides Update on 2014 Operational and Preliminary Financial Results
read more
View Summary PRESS RELEASEDec 22, 2014
NanoString Technologies to Present at J.P. Morgan 33rd Annual Healthcare Conference
read more
View Summary PRESS RELEASEDec 15, 2014
NanoString Technologies Highlights Important Results from Prosigna Decision Impact Study Presented at the 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium
read more
View Summary PRESS RELEASEDec 08, 2014
NanoString Technologies Updates Prosigna FDA Labeling to Provide Greater Insight into Probability of Breast Cancer Recurrence Between Year 5 and 10 After Diagnosis
read more
Showing 1-20 of 119 Page: 1 2 3 4 5 6  Next 20